Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

Dr. Ali Sherif normally gives about 50 doses of the measles vaccine to children each month at his clinic in Hobbs, New Mexico ...

India may ban the widely used antacid ranitidine as an expert panel submits a report highlighting cancer risks and NDMA ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ... As on 31-03-2025, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2815.40. On previous day, ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Small airways disease may be evaluated with a single inspiratory CT scan using generative artificial intelligence (AI).

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

Canada is just emerging from another winter wave of multiple infectious diseases only for the population to be confronted ...